Over the past few decades, most of the innovation surrounding the healthcare industry has been centered on companies developing new diagnostics, drugs, therapies, or devices. Moving forward, innovation may shift its effort to other areas such as prevention, more personalized care, and more efficient technology-enabled care models. Frost & Sullivan Healthcare and Life Sciences experts are predicting large disruptions and transformations to the industry as it continues to leave behind outdated business models. “Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as artificial intelligence and blockchain will help shape the healthcare industry into a much-anticipated, value-based care paradigm” commented Sandeep Sinha, VP & Head, Healthcare and Life Sciences, Frost & Sullivan. Recently, healthcare stocks have become a large focus of conversation among investors as the number of headlines regarding the sector have been soaring. As healthcare companies work around the clock to develop novel and effective solutions to improve the quality of care, there has been constant excitement surrounding the sector and healthcare stocks.Click Here For Today's Trending Biotech Stocks